Skip to main content

Table 2 PD in minimum absorbed doses to 25%, 50%, and 75% (D25, D50, D75) of the lesion VOI volume compared against MC. The PD was formed per lesion and then averaged over all lesion giving the presented value

From: Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T

Method VSVsoft
Mean ± SD
\( {\mathbf{VSV}}_{\mathbf{weighted}}^{\mathbf{soft}} \)
Mean ± SD
VSVsoft+bone
Mean ± SD
\( {\mathbf{VSV}}_{\mathbf{weighted}}^{\mathbf{soft}+\mathbf{bone}} \)
Mean ± SD
PD of D25 [%] 15 ± 14 − 4 ± 2 − 36 ± 8 − 2 ± 2
PD of D50 [%] 17 ± 11 − 4 ± 2 − 35 ± 6 − 2 ± 2
PD of D75 [%] 18 ± 10 − 5 ± 1 − 34 ± 6 − 2 ± 1